Savient Pharmaceuticals to Present at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference
02 November 2005 - 10:30PM
Business Wire
Savient Pharmaceuticals Inc. (NASDAQ: SVNTE), an emerging specialty
pharmaceuticals company focused on developing, manufacturing and
marketing novel therapeutic products for unmet medical needs, today
announced that Christopher Clement, President and Chief Executive
Officer, will present at the Rodman & Renshaw Techvest
Healthcare Conference on Wednesday, November 9, 2005 at 11:15 a.m.
EST at the New York Palace Hotel. A live webcast of the
presentation can be accessed under the News section of Savient's
website at www.savientpharma.com and will be archived through
November 23, 2005. Please connect to the website several minutes
prior to the start of the presentation to ensure adequate time for
any software download that may be required. About Savient
Pharmaceuticals, Inc. Based in East Brunswick, New Jersey, Savient
Pharmaceuticals, Inc. is a specialty pharmaceutical company
dedicated to developing, manufacturing and marketing novel
therapeutic products that address unmet medical needs. The
Company's lead product development candidate, Puricase(R), for the
treatment of refractory gout has reported positive Phase 1 and 2
clinical data. Savient's experienced management team is committed
to advancing its pipeline and expanding its product portfolio by
in-licensing late stage compounds and exploring co-promotion and
co-development opportunities that fit the Company's expertise in
specialty pharmaceuticals and initial focus in rheumatology. The
Company's operations also include a wholly-owned U.K. subsidiary,
Rosemont Pharmaceuticals Ltd., which develops, manufactures and
markets liquid formulations of prescription pharmaceutical
products. Rosemont's product portfolio includes over 90 liquid
formulations primarily targeting the geriatric population. Further
information on the Company can be accessed by visiting
www.savientpharma.com.
Savient (NASDAQ:SVNTE)
Historical Stock Chart
From May 2024 to Jun 2024
Savient (NASDAQ:SVNTE)
Historical Stock Chart
From Jun 2023 to Jun 2024
Real-Time news about Savient Pharmaceuticals (MM) (NASDAQ): 0 recent articles
More Savient Pharmaceuticals, Inc. News Articles